The emergence of Kawasaki disease in India and China

Authors

  • Ankur Kumar Jindal Allergy Immunology Unit, Department of Pediatrics, Advanced Pediatrics Centre, PGIMER, Chandigarh, India
  • Vingesh Pandiarajan Allergy Immunology Unit, Department of Pediatrics, Advanced Pediatrics Centre, PGIMER, Chandigarh, India
  • Raju Khubchandani Department of Pediatrics, Jaslok Hospital, Mumbai, India
  • Nutan Kamath Department of Pediatrics, Kasturba Medical College, Mangalore, India
  • Tapas Sabui Department of Pediatrics, RG Kar Medical College, Kolkata, India
  • Rakesh Mondal Institute of Post Graduate Medical Education and Research, Kolkata, India
  • Priyankar Pal Institute of Child Health, Kolkata, India
  • Surjit Singh Allergy Immunology Unit, Department of Pediatrics, Advanced Pediatrics Centre, PGIMER, Chandigarh, India

DOI:

https://doi.org/10.21542/gcsp.2017.21

Abstract

Kawasaki disease (KD) is recognized as a leading cause of acquired heart disease in children in developed countries. Although global in distribution, Japan records the highest incidence of KD in the world. Epidemiological reports from the two most populous countries in the world, namely China and India, indicate that KD is now being increasingly recognized. Whether this increased reporting is due to increased ascertainment, or is due to a true increase in incidence, remains a matter of conjecture. The diagnosis and management of KD in developing countries is a challenging proposition. In this review we highlight some of the difficulties faced by physicians in managing children with KD in resource-constrained settings. 

Downloads

Published

2018-01-07

Issue

Section

Review articles